Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | RGMB | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | PML | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | RTN1 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | MTRNR2L10 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | TRERF1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | TEAD1 | CCLE | pan-cancer | AAC | -0.19 | 0.008 |
mRNA | EXOSC2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
mRNA | DLL3 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | SFT2D2 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |